Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
Daiichi Sankyo
Sara A Hurvitz; Roberto Hegg; Wei-Pang Chung; Seock-Ah Im; William Jacot; Vinod Ganju; Joanne Wing Yan Chiu; Binghe Xu; Erika Hamilton; Srinivasan Madhusudan; Hiroji Iwata; Sevilay Altintas; Jan-Willem Henning; Giuseppe Curigliano; José Manuel Perez-Garcia; Sung-Bae Kim; Vanessa Petry; Chiun-Sheng Huang; Wei Li; Jean-Sebastien Frenel; Silvia Antolin; Winnie Yeo; Giampaolo Bianchini; Sherene Loi; Junji Tsurutani; Anton Egorov; Yali Liu; Jillian Cathcart; Shahid Ashfaque; Javier Cortés